FAD
发表于 2025-3-21 16:05:32
书目名称Direct Oral Anticoagulants影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0280625<br><br> <br><br>书目名称Direct Oral Anticoagulants影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0280625<br><br> <br><br>书目名称Direct Oral Anticoagulants网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0280625<br><br> <br><br>书目名称Direct Oral Anticoagulants网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0280625<br><br> <br><br>书目名称Direct Oral Anticoagulants被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0280625<br><br> <br><br>书目名称Direct Oral Anticoagulants被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0280625<br><br> <br><br>书目名称Direct Oral Anticoagulants年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0280625<br><br> <br><br>书目名称Direct Oral Anticoagulants年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0280625<br><br> <br><br>书目名称Direct Oral Anticoagulants读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0280625<br><br> <br><br>书目名称Direct Oral Anticoagulants读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0280625<br><br> <br><br>
Itinerant
发表于 2025-3-21 21:12:49
http://reply.papertrans.cn/29/2807/280625/280625_2.png
modish
发表于 2025-3-22 01:43:31
Pharmacokinetics and Pharmacodynamics of DOAC, dabigatran (a reversible direct thrombin inhibitor) and the direct factor Xa inhibitors rivaroxaban, apixaban, and edoxaban offer fixed dosing, more predictable pharmacokinetics and fewer interactions with drugs and food than warfarin. Results from clinical trials demonstrated an improved benefit-r
先锋派
发表于 2025-3-22 05:32:17
http://reply.papertrans.cn/29/2807/280625/280625_4.png
Urea508
发表于 2025-3-22 10:47:33
http://reply.papertrans.cn/29/2807/280625/280625_5.png
粗语
发表于 2025-3-22 13:59:12
Risk Stratification For and Use of DOAC Therapies for Stroke Prevention in Patient with Atrial Fibrant agents play a key role in preventing this complication. Through years, several risk stratification algorithms have been investigated, while others are still object of debate. According to current guidelines, CHA2DS2VASc score and HAS-BLED score are the ones suggested for stroke and bleeding risk
粗语
发表于 2025-3-22 20:39:30
Use of DOAC in Patients with Kidney Disease,morrhagic events are increased in patients with kidney disease. Oral anticoagulation therapy, nowadays preferably with direct oral anticoagulants (DOACs), represents the cornerstone for ischemic stroke prevention in high-risk patients. However, all four available DOACs (dabigatran, apixaban, rivarox
falsehood
发表于 2025-3-23 00:26:33
http://reply.papertrans.cn/29/2807/280625/280625_8.png
echnic
发表于 2025-3-23 03:09:14
,The “Obesity Paradox” and the Use of NOAC,ovascular (CV) risk, more and more evidences suggest a favorable prognosis in obese subjects with cardiovascular disease (CVD), a phenomenon known as “obesity paradox.” Obesity paradox has been demonstrated in various CVD including atrial fibrillation (AF) and venous thromboembolism (VTE) for which
反抗者
发表于 2025-3-23 05:41:57
http://reply.papertrans.cn/29/2807/280625/280625_10.png